Literature DB >> 11796781

A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances.

R Queralt1, M Ezquerra, A Lleó, M Castellví, J Gelpí, I Ferrer, N Acarín, L Pasarín, R Blesa, R Oliva.   

Abstract

A novel mutation (V89L) in the presenilin 1 (PSEN1) gene is described in a family with pathologically confirmed Alzheimer's disease. The mutation was identified in two affected members with early onset Alzheimer's disease characterised by early and marked behavioural disturbances. The mutation is located on the same side of the helix as other described mutations in the first transmembrane domain and its relation to other mutations in this helix suggests that they share a common pathogenic mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796781      PMCID: PMC1737723          DOI: 10.1136/jnnp.72.2.266

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

Review 1.  Young onset dementia.

Authors:  E L Sampson; J D Warren; M N Rossor
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

2.  Early psychiatrics symptoms in familial Alzheimer's disease with presenilin 1 mutation (I83T).

Authors:  Saloua Fray; Nadia Ben Ali; Afef Achouri Rassas; Meriem Kechaou; Nouria Oudiaa; Aroua Cherif; Slim Echebbi; Taieb Messaoud; Samir Belal
Journal:  J Neural Transm (Vienna)       Date:  2015-12-22       Impact factor: 3.575

Review 3.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

Review 4.  Correlating familial Alzheimer's disease gene mutations with clinical phenotype.

Authors:  Natalie S Ryan; Martin N Rossor
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

5.  Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation.

Authors:  María-Ximena Silveyra; Geneviève Evin; María-Fernanda Montenegro; Cecilio J Vidal; Salvador Martínez; Janetta G Culvenor; Javier Sáez-Valero
Journal:  Mol Cell Biol       Date:  2008-02-25       Impact factor: 4.272

Review 6.  The paradox of syndromic diversity in Alzheimer disease.

Authors:  Jason D Warren; Phillip D Fletcher; Hannah L Golden
Journal:  Nat Rev Neurol       Date:  2012-07-17       Impact factor: 42.937

7.  Corticobasal Syndrome in a Family with Early-Onset Alzheimer's Disease Linked to a Presenilin-1 Gene Mutation.

Authors:  Eloisa Navarro; Clara De Andrés; Carmen Guerrero; Santiago Giménez-Roldán
Journal:  Mov Disord Clin Pract       Date:  2015-07-25

Review 8.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

Review 9.  The genetics of Alzheimer's disease.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2014-04-01       Impact factor: 4.458

10.  Probable novel PSEN2 Val214Leu mutation in Alzheimer's disease supported by structural prediction.

Authors:  Young Chul Youn; Eva Bagyinszky; HyeRyoun Kim; Byung-Ok Choi; Seong Soo An; SangYun Kim
Journal:  BMC Neurol       Date:  2014-05-15       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.